By Stephanie Baringer Since the FDA’s founding in 1906, the agency has only approved approximately 140 drugs to treat diseases of the central nervous system1, compared to over 450 drugs to treat various cancers2. While there are a variety of reasons for this dichotomy, one is the difficulty of getting drugs into the brain due … Continue reading How Tf Do We Get This Drug in the Brain?

By Jessica Heebner As of July 2022, your money is able to buy, on average, 9.1% less than it was last July. What does that mean, exactly? How are you making more money (if you were lucky enough to get any raise at all) but your money buys less? It’s all due to inflation. Stick … Continue reading What’s the Big Deal with Inflation?

By Christopher Kendra Little Susie went about her Saturday like a normal 14 year-old girl. She woke up, watched cartoons, contemplated dismantling the patriarchy and had her favorite sandwich for lunch. Later in the day, she did in fact dismantle the patriarchy, but that’s not the point of this article. By Tuesday, Susie felt nauseous … Continue reading Tracking the Pathogen: Foodborne Outbreaks

By Ian Hayman You’re sitting in lab, fiddling with the newest duct tape/wire/clamp/tubing/ring stand amalgamation you jury-rigged to support your experimental apparatus. Everything looks good (or as good as it can look), so you start your experiment and head to lunch. Calamity strikes. Upon returning to lab, your monstrosity has fallen apart and your precious … Continue reading Tea! Earl Grey! Hot! How Star Trek Replicators are not so Sci-Fi After All